In this roundtable discussion, nation's leading cancer experts from across the country share their perspectives on current changes, challenges and opportunities for delivering cancer care during the COVID-19 era. The roundtable panel examines long-term implications of the pandemic on the management and treatment of cancer especially focusing on significant issues in patient safety, toxicities associated with the use of immunotherapy, COVID-19 vaccination, and clinical trial designs. In this discussion, experts also brainstorm a range of recommendations focusing especially on how the cancer community can capitalize on lessons learned from the pandemic to develop creative approaches that can be taken forward.
RCTs and other clinical trial designs in Ayurveda: A review of challenges and opportunities
